Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial

BACKGROUND: To optimize vaccine implementation visits for young children, it could be efficient to administer the first RTS,S/AS01 malaria vaccine dose during the Expanded Programme on Immunization (EPI) visit at 6 months of age together with Vitamin A supplementation and the third RTS,S/AS01 dose o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Vaccine
Autors principals: Asante, Kwaku Poku, Ansong, Daniel, Kaali, Seyram, Adjei, Samuel, Lievens, Marc, Badu, Lydia Nana, Darko, Prince Agyapong, Buabeng, Patrick Boakye Yiadom, Boahen, Owusu, Rettig, Theresa Maria, Agutu, Clara, Harrison, Samuel Benard Ekow, Ntiamoah, Yaw, Anim, Japhet Adomako, Adeniji, Elisha, Dornudo, Albert Agordo, Gvozdenovic, Emilia, Dosoo, David, Sambian, David, Owusu-Boateng, Harry, Wilson, Elvis Ato, Prempeh, Frank, Vandoolaeghe, Pascale, Schuerman, Lode, Owusu-Agyei, Seth, Agbenyega, Tsiri, Ofori-Anyinam, Opokua
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7611265/
https://ncbi.nlm.nih.gov/pubmed/32192811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.03.014
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars